Primary Malignant Myelomatous Pleural Effusion- what we Learned from Past
Asian Hematology Research Journal,
Multiple myeloma forms 10% of all haematological malignancies and of these approximately 1-18% has pleural effusion at some point in their life time. The aetiology of primary malignant myelomatous pleural effusion (PMMPE) is quite varied with defined diagnostic criteria. It usually effects the middle aged males with Ig G or IgA as the dominant variant. Besides the prognostic factors used for the multiple myeloma, the morphology of the cells in effusion also matters and have to be focused. With more aggressive chemo regimens and the newer agents the median overall survival improved from 2.4 months to more than 18 months and all the subjects should be aggressively treated, wherever possible. However in patients, who develop effusion in the course of therapy, the prognosis is poor and median survival is only four months despite HDC-SR (irrespective of the initial stage)
- plasma cell
How to Cite
Yanamandra U, Deo P, Sahu KK, Nampoothiri RV, Gupta N, Prabhakaran A, et al. Clinicopathological Profile of Myelomatous Pleural Effusion: Single-center Real-world Experience and Review of Literature. Clin Lymphoma Myeloma Leuk. 2019;19(3): 183-189.e1. DOI: 10.1016/j.clml.2018.12.003 Epub 2019 Jan 3. PMID: 30704934.
Attili VS, Singh VP, Sundar S, Mehta H, Negi ML, Gogia A, et al. Malignant myelomatous pleural effusion with good response to combination chemotherapy. J Assoc Physicians India. 2007;55:595-6. PMID: 18019805.
Attili S, Ullas B, Lakshm D, Bapsy PP, Lakshm KC, Govind K, et al. Malignant myelomatous pleural effusion-Is onset of effusion a new prognostic factor? Turk J Haematol. 2007;24(4):181-5. PMID: 27263959.
Mangla A, Agarwal N, Kim GJ, Catchatourian R. Primary malignant myelomatous pleural effusion. Clin Case Rep. 2016;4(8):803-806. Published 2016 Jul 15. DOI: 10.1002/ccr3.634
Rodelo A, Joshi J. Myelomatous Pleural Effusion as a Presenting Symptom: A Case Report. Cureus. 2019;11(7):e5153. DOI: 10.7759/cureus.5153 PMID: 31523580; PMCID: PMC6741372.
Kamble R, Wilson CS, Fassas A, Desikan R, Siegel DS, Tricot G, et al. Malignant pleural effusion of multiple myeloma: prognostic factors and outcome. Leuk. Lymphoma. 2005;46:1137–1142.
Xu XL, Shen YH, Shen Q, et al. A case of bilateral pleural effusion as the first sign of multiple myeloma. Eur J Med Res. 2013; 18:7.
Rodríguez JN, Pereira A, Martínez JC, Conde J, Pujol E. Pleural effusion in multiple myeloma. Chest. 1994;105:622-4.
Dhingra KK, Singhal N, Nigam S, Jain S. Unsuspected multiples myeloma presenting as bilateral pleural effusion – A cytological diagnosis. Cytojournal. 2007;4: 17.
Jasmine Sekhon, Divya Vangipuram, Ximena Solis. Primary malignant myelomatous effusion in multiple myeloma patient. Chest Journal. 2020;158(4): A2567.
Alexander V, Binu AJ. Sathyendra SMyelomatous pleural effusion and extensive extraskeletal soft tissue involvement: A rare presentation of clonal plasma cell disorders. BMJ Case Reports CP. 2019;12:e230560.
Li-Li Zhang, Yuan-Yuan Li, Cheng-Ping Hu, Hua-Ping Yang. Myelomatous pleural effusion as an initial sign of multiple myeloma—a case report and review of literature. Journal of Thoracic Disease. 2014;7(6).
Uskül BT, Türker H, Emre Turan F, et al. Pleural effusion as the first sign of multiple myeloma. Tuberk Toraks 2008; 56:439-42
Oudart JB, Maquart FX, Semouma O, et al. Pleural effusion in a patient with multiple myeloma. Clin Chem. 2012; 58:672-4.
Keklik M, Sivgin S, Pala C, et al. Flow cytometry method as a diagnostic tool for pleural fluid involvement in a patient with multiple myeloma. Mediterr J Hematol Infect Dis. 2012;4:e2012063.
Alicia martinez-iribarren, carla fernandez-prendes; A case of myelomatous pleural effusion: an unusual onset of multiple myeloma. Blood. 2020; 135 (2):153. DOI: https://doi.org/10.1182/blood.2019002471
U. Adil, H. Youness. Primary malignant myelomatous pleural effusion: A rare entity. American Journal of Respiratory and Critical Care Medicine. 2019; 199:A6390. Available:https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A6390
Abstract View: 71 times
PDF Download: 26 times